Related Experiment Video
Updated: Jun 14, 2026

12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Lichen planus pemphigoides, a possible example of epitope spreading
Michele D Mignogna1, Giulio Fortuna, Stefania Leuci
1Oral Medicine Unit, Department of Odontostomatologic and Maxillofacial Science, School of Medicine and Surgery, Federico II University of Naples, Naples, Italy. mignogna@unina.it
Summary
Two female patients initially diagnosed with oral lichen planus later developed mucous membrane pemphigoid. Intravenous immunoglobulin therapy proved effective for both conditions, suggesting epitope spreading as a potential mechanism.
Area of Science:
- Immunology
- Dermatology
- Oral Medicine
Background:
- Oral lichen planus (OLP) and mucous membrane pemphigoid (MMP) are distinct autoimmune chronic inflammatory diseases.
- OLP involves a cell-mediated (lymphocytic) autoimmune response, while MMP is characterized by antibody-mediated (humoral) autoimmune activity.
Observation:
- This study reports two female patients initially diagnosed with OLP.
- These patients subsequently developed MMP over a 3 to 11-year period.
- Both conditions were diagnosed using clinical, histological, and immunological assessments.
Findings:
- The patients' conditions were refractory to standard immunosuppressive treatments.
- Both OLP and MMP in these cases responded well to intravenous immunoglobulin (IVIg) therapy.
- The findings suggest a potential progression from OLP to MMP in these patients.
Implications:
- Further research is needed to understand the progression from one autoimmune disorder to another.
- Epitope spreading is hypothesized as a potential underlying mechanism for this progression.
- This case series highlights IVIg as a potential therapeutic option for refractory OLP and MMP.
Related Concept Videos
Cross-reactivity
Overview
Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.

